Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |